gastroparesis semaglutide If you are hearing more about and GLP-1 medications, you are not imagining it. Gastroparesis is a real condition, and patients who experience severe symptoms deserve to be heard. Increased media Internet searches on weight-loss medications

Genetic testing costs $99 as an add-on after your first month of treatment, providing personalized guidance for optimizing your therapeutic dose

In the phase 3 MAESTRO-NASH trial, resmetirom significantly increased the rate of NASH resolution and improved fibrosis outcomes in patients with NASH and coexisting liver fibrosis (Harrison et al., 2024)

Today there are various energy-based technologies designed to treat facial lines and wrinkles

In recent years, the FDA has begun approving GLP-1s specifically for chronic weight management to help treat obesity, as they can increase satiety, decrease hunger and result in significant weight loss

,